Foveal thickness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema

AIM To report foveal thickness reduction in eyes with resolution of macular edema and recovery of a foveal depression after one-year of anti-vascular endothelial growth factor (anti-VEGF) therapy for center-involving diabetic macular edema (DME).